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ABSTRACT: Diabetes mellitus is a common problem in clinical practice.  An indigenous herbal 
drug Arani (Clerodendron phlomidis) was selected for this experimental and clinical study.  The 
experimental study was conducted on albino rats.  Arani inhibited the adrenaline induced 
hyperglycaemia effectively.  The alcoholic extractive of Arani produced a well comparable fall in 
blood sugar to that of tolbutamide.  Moreover, Arani caused a significant fall in hyperglycaemia 
ofalloxan diabetic patients along with clinical improvement.  The results were found quite 
comparable to tolbutamide. 
 
INTRODUCTION 
 
Diabetes mellitus is a most common 
metabolic disorder of human beings.  It is 
global in distribution affecting 2 to 6 percent 
population of the World.  Gupta et al. (1975) 
have reported the incidence of diabetes 
mellitus more in Indian urban community 
(3.04)% than rural population (1.29%).   
Caraka and Susruta (400 B. C.) have 
discussed the honey urine (Madhumeha) in 
detail.  However the name ‘Diabetes’ was 
given by two Roman physicians, Celsus and 
Aretaeus in          1
st A. D. and in 1921, 
Banting and Best solved the problem to a 
great extent by extracting the insulin from 
pancreas.  But the long term complications 
are not preventable by the present mode of 
therapy.  Insulin is available in various 
forms but prick pain, risk of hypoglycaemic 
encephalopathy, and possibility of 
development of insulin antibodies on long 
term use limit its utility.  Oral 
hypoglycaemic agents also poses some side 
effects.  
 
In Ayurveda, various herbs like Haridra, 
Jamun, Karela etc. have been prescribed for 
the treatment of Madhumeha.  Susruta has 
given the emphasis on the utility of 
Vaijayanti (Arani) in Iksumeha (Su. Ci. 
11/9).  There are found two varieties of 
Arani  –  big and small.  Shankaran et al. 
(1963) have studied the effect of one variety 
of Arani Premna integrifolia in diabetes 
mellitus.  Therefore another variety of Arani 
i.e. Clerodendron phlomidis (Fig. 1) was 
selected for this study.  This plant of about 9 
meter heigh belongs to Verbenaceae family.  
Arani is one of the ingredient of Brhat Panca 
Mula.  Arani is bitter and pungent in taste, 
katu in Vipaka and Usna in Virya.  It 
normalizes the vitiated Kapha and Vata 
Dosa. 
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However, the foundation of therapeutics lies 
on the experimental analysis.  Therefore, 
controlled experiments were carried out in 
this study.  Effects of decoction and 
alcoholic extractives of Arani were observed 
in adrenaline induced hyperglycaemia.  The 
results were compared with Tolbutamide.   
The effect of Arani was also seen on alloxan 
diabetic rats.  Moreover a clinical trial was 
also conducted to evaluate the anti diabetic 
effect of Arani.  The results were 
encouraging.  The details of these 
experimental and clinical studies are being 
described here. 
 
EXPERIMENTAL STUDY 
 
Material and Methods: 
 
Different solvent extractive of Arani were 
prepared and their effect on fasting blood 
sugar levels were studied in normal rats.   
Alcoholic extractive exhibited greatest 
hypoglycaemic effect.  Therefore the 
alcoholic extractive of Arani along with 
decoction of Arani (because of popular use 
of decoction of Ayurvedic herbal drugs) was 
subjected to observe anti –  blood sugar 
effect. 
 
In the first experiment the effect of Arani 
was studied in adrenaline induced 
hyperglycaemia.  24 albino rats were 
divided into four groups of six each.  After 
an overnight fast, blood samples were taken.  
Then animals were fed with their respective 
drugs.  The decoction of Arani was given to 
the first group in doses of 4 ml. (1.0 gm crud 
drug) per day to each rat.  The rats of third 
group  were treated with a known oral 
hypoglycaemic drug, tolbutamide, doses of 
500 mg/kg body weight per day.  The fourth 
group was taken as control.  After half an 
hour of feeding, adrenaline hydrochloride 
was injected subcutaneously to each rat in 
doses of 0.5 mg. per kg. body weight.  The 
blood samples were then collected at first 
hour, second hour and third hour for sugar 
estimation. 
 
In the second experiment of comparative 
study of tolbutamide and Arani decoction 
was done in two steps in separate groups 
each of six healthy albino rats.  In the first 
step, after a fast for 18 hours blood samples 
were taken and then tolbutamide (500 
mg/kg) was given to first group and Arani 
decoction (4.0 ml = 1.0 gm. crude drug / rat) 
was fed to another group.  Blood sugar 
values were then estimated after one hour, 
two hours and three hours.  In the second 
step tolbutamide and Arani decoction were 
given to separate groups in above mentioned 
doses for one month.  Blood samples were 
collected at the end of 10 days, 20 days and 
finally after 30 days. 
 
The effect of decoction and alcoholic 
extractive of Arani on blood sugar of 
alloxan diabetic rats were studied in the 
third experiment.  18 healthy rats were taken 
for this study.  Alloxan monohydrate was 
given to them in doses of 150 mg/kg 
intraperitoneally.  Glucose solution (10 – 
15%) was given orally till permanent 
hypoerglycaemia was established.  After 3 – 
4 days animals required insulin (2 – 4 units) 
daily in addition of feeding.  Only those 
animals which showed hyperglycaemia even 
after a period of 10 days of alloxan 
administration, were selected for this study.  
Insulin and feeding were discontinued for 
two days and fasting samples were taken.   
Then animals were divided into three 
groups.  One group was orally fed with 4 ml. 
decoction (1.0 gm crude drug); other with 
0.5 ml of alcoholic extractive of Arani (2.0 
gm crud drug) and the last with 4 ml. of 
water daily to each rat.  Blood samples were 
then taken after two hours and four hours. 
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RESULTS AND OBSERVATIONS: 
 
The different blood sugar values obtained in 
the first experiment are given in table – 1.  
The highest rise in blood sugar level was 
obtained at the end of second hour of 
adrenaline injection.  Thereafter the blood 
sugar contents began to fall.  The observed 
mean percent rise per hour by adrenaline in 
the Arani –  alcoholic extractive treated 
group was 5.28.  It was well comparable to 
that observed in tolbutamide group (2.23). 
However, in Arani – decoction treated group 
the mean percent rise was more i.e. 10.9. 
 
The second experiment was conducted in 
two steps.  The table-2 denotes the blood 
sugar values for the first step of experiment.  
It is evident from this table that Arani 
decoction and tolbutamide produced 8.3 and 
10.0 mean percent reduction per hour 
respectively in blood sugar of healthy rats.  
Both were significant on statically analysis.   
Blood sugar values of animals after 10 days, 
and 20 days and 30 days of administration of 
Arani decoction and tolbutamide are given 
in table 3.  Mean percentage reduction after 
one month was 20.7 and 35.5 in animals 
treated with Arani decoction and 
Tolbutamide respectively.  The mean % 
reduction in Arani decoction group was 8.31 
after 3 hours and 20.7 after one month 
whereas this mean% reduction in 
tolbutamide group was 10 and 35.4 
respectively. 
 
 
TABLE – I 
 
Effect of Arani (decoction and alcoholic extractive) and Tolbutamide in Adrenaline 
induced Hyperglycaemia 
 
S. 
No. 
Drug  MEAN BLOOD SUGAR VALUES (mg%)  Mean % 
Rise per 
hour 
Fasting  1 Hour  II Hour  III Hour 
1. 
 
2. 
 
 
3. 
 
 
4. 
Adrenaline (Adr.) 
 
Adr + Arani 
decoction 
 
Adr. + Alcoh. Ext. 
of Arani. 
 
Adr. + 
Tolbutamide 
81.88 ± 3.30 
 
84.55 ± 3.90 
 
 
85.55 ± 3.90 
 
 
70.00 ± 3.30 
 
116.88 ± 5.60 
 
203. 39 ± 4.50 
 
 
101.33 ± 3.50 
 
 
79.33 ± 3.70 
204.22 ± 14.70 
 
128.09 ± 4.40 
 
 
113.33 ± 3.20 
 
 
101.11 ± 4.40 
156.66 ± 10.30 
 
112.10 ± 4.30 
 
 
101.11 ± 4.40 
 
 
85.33 ± 3.20 
30.90 
 
10.90 
 
 
5.28 
 
 
2.23 
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TABLE – II 
 
Hourly changes in blood sugar levels of rats treated with Arani decoction and tolbutamide 
 
S. 
No. 
Drug  MEAN BLOOD SUGAR (mg %)  Mean % 
reduction 
/ hour 
‘t’  ‘p’ 
Fasting  I Hour  II Hour  III Hour 
1 
 
 
2 
Arani 
 
 
Tolbutamide 
81. 29 ± 
5.70 
 
75.33 ± 
2.80 
61.24 ± 
3.50 
 
46.67 ± 
2.20 
55.05 ± 
2.70 
 
44.67 ± 
3.30 
58.28 ± 
7.40 
 
52.00 ± 
5.40 
8.31 
 
 
10.00 
2.25 
 
 
2.25 
< 0.05 
 
 
< 0.05 
 
 
TABLE – III 
 
Blood sugar values at 10 days interval in normal rats treated with Arani decoction and 
tolbutamide 
 
S. 
No. 
Drug  MEAN BLOOD SUGAR (mg %)  Mean % 
Reduction 
after 30 
days 
‘t’  ‘p’ 
Initial  Days after administration 
10  20  30 
1 
 
 
2 
Arani 
 
 
Tolbutamide 
70. 80 
± 4.30 
 
65.60 ± 
4.70 
60.00 
± 4.60 
 
33.46 
± 3.20 
59.66 ± 
4.80 
 
44.66 ± 
2.50 
59.90 ± 
2.30 
 
42.40 ± 
3.10 
 
20.70 
 
 
35.40 
4.30 
 
 
5.32 
< 0.01 
 
 
< 0.001 
 
 
TABLE – IV 
 
Effect of decoction and alcoholic extractive of Arani in blood sugar of alloxan diabetic rats 
 
S. 
No. 
Drug  BLOOD SUGAR (mg%)  Mean % 
reduction 
per hour 
‘t’  ‘p’ 
Fasting   2 Hours  4 Hours 
1 
 
 
2 
 
 
3 
Arani decoction 
 
 
Alcoh. Extr. Of 
Arani 
 
Control 
258.33 
± 23.00 
 
228.00 
± 19.00 
 
245.34 
± 25.10 
167.76 ± 
9.60 
 
146.56 ± 
17.00 
 
217.32 ± 
23.10 
165.76 ± 
11.50 
 
121.32 ± 
14.00 
 
196.66 ± 
21.10 
27.28 
 
 
27.83 
 
 
23.13 
3.70 
 
 
4.74 
 
 
- 
<0.05 
 
 
<0.05 
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TABLE – V 
 
Statistical analysis of values of Table - I 
 
Time  Adr. + Deco  Adr. + Alcoh. Ext.  Adr. + Tolb 
‘t’  ‘p’  ‘t’  ‘p’  ‘t’  ‘p’ 
I Hour 
 
II Hour 
 
III Hour 
2.0 
 
5.90 
 
8.92 
>0.05 
 
<0.01 
 
<0.01 
2.4 
 
8.33 
 
7.26 
>0.05 
 
<0.001 
 
<0.001 
4.42 
 
9.78 
 
7.91 
<0.01 
 
<0.001 
 
<0.001 
 
 
TABLE – VI 
 
The Response of Arani in Diabetes Mellitus (13 Cases) 
 
S. No.  Category  Blood Sugar  Urine sugar  No. of 
patients 
% 
1 
 
2 
 
3 
 
4 
Good 
 
Fair 
 
Poor 
 
Unfollowed 
Normal 
 
Near Normal 
 
Above normal 
 
- 
Absent 
 
Markedly reduced 
 
Reduced 
 
- 
6 
 
3 
 
3 
 
1 
46 
 
23 
 
23 
 
8 
 
 
The values of blood sugar as obtained in 
third experiment in alloxan diabetic rats are 
given in table 4 control groups which was 
treated with plain water showed 13% fall per 
hour.  In the group of Arani decoction 
treated rats, reduction % per hour was 27.78, 
and for alcoholic extractive treated group 
were 27.83. 
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DISCUSSION 
 
The adrenaline induced hyperglycaemia is 
the result of mobilization of liver glycogen, 
reduction in muscle glycogen, reduction in 
muscle glycogen with the conversion of 
resultant lactic acid to blood sugar in the 
liver, and diminution in peripheral glucose 
utilization (Sutherland, 1952).  It is evident 
from table – 1 that both prepartions of Arani 
– decoction and alcoholic extractive inhibit 
adrenaline induced hyperglycaemia.   
However, alcoholic extractive revealed 
greater inhibitory effect at the end of second 
hour as compared with that of decoction.  
Both of these preparations exhibited 
significant inhibition in rise of blood sugar 
after 2
nd and 3
rd hour of adrenaline injection.  
A greater significant ‘p’ value -  <0.001 
(Table – 5), was observed in 2
nd and 3
rd hour 
in the alcoholic extractive treated group.  It 
shows more inhibitory action of alcohol 
extractive on adrenaline response of animals 
than that of decoction of Arani.  The results 
are well depicted in Fig.2. 
 
Janbon and his associated (1942), firstly 
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sulfonamides.  However in 1955, Frank and 
Fuschs confirmed the blood sugar lowering 
action of carbutamide, a sulfonamide using 
it for an infectious disease.  But the 
incidence of side effects was considered to 
be high for general use.  Sooner, the first 
sulfonyl urea compound, tolbutamide was 
introduced for general use in diabetes in U S 
A in 1957.  Tolbutamide was well described 
by Kautz (1957), the secretory of Council on 
Drugs (America).  It stimulates the release 
of  insulin by beta cells and also inhibts 
neoglucogenesis and glycogenolysis.   
Kulkarni and Gaitonde (1962) have reported 
24% fall in fasting blood sugar of rats after 4 
hours of Tolbutamide (500 mg/kg) 
administrations.  In the present series it was 
29% after 3
rd hour.  It is well comparable 
(Table – 2).  The fall with both the Arani 
decoction and tolbutamide was found 
significant (p<0.05).   It appears, therefore, 
that the decoction of Arani compared 
favourably with Tolbutamide in its 
immediate effect.  Moreover, decoction of 
Arani also produced a fall of 20.7% on long 
term use for a month (Table – 3) which is 
also comparable to fall produced by Jasad 
Bhasma i.e. 22% observed by Kulakarni and 
Gaitoned (1962).  This fall percentage of 
Arani decoction after a month use was found 
highly significant (<0.01).  However, it was 
somewhat less than that of Tolbutamide 
(35.4%) which was also more significant 
(p<0.001). 
 
There are certain chemical agents like 
alloxan, streptozotocni, Vacor (rat poison) 
which produce hypoinsulinomic diabetes 
mellitus.  However, alloxan is still the 
popularly used compound to produce 
experimental diabetes in animals.  Dunn et 
al. (1943) reported the selective necrosis of 
beta cells in islets of Langerhans by alloxan.  
Many indigenous drugs have been studied in 
past for their effective hypoglycaemic action 
in alloxan diabetes.  Jambu (Eugenea 
jambolana), Nimba, (Melia azadirachta) and 
Udumbara (Ficus glomerata), Asvattha 
(Ficus religiosa) and Plaksa (Ficus 
bangalensis), have all been investigated by 
Gujarat et al. (1954).  In the present study 
Arani was tried in alloxan diabetic rats.   
Results are given in table-4.  It appears that 
the administration of both the decoction and 
alcoholic extractive of Arani brought down 
the blood sugar levels effectively by the end 
of second hour and showed sustained 
hypoglycaemic effect at the end of 4
th hour 
of study.  Both the preparations of Arani 
exhibited the same degree of hypoglycaemic 
action in alloxan diabetic rats.  No 
difference in mean reduction percentage per 
hour was observed.  This value was 20.78 
for decoction group and 27.83 for alcoholic 
extractive group.  The pattern of fall in 
blood sugar values in either groups, also 
compares well with each other.  Both 
exhibited equally significant (p<0.05) effect 
in comparison to control. 
 
Moreover, in adrenaline induced 
hyperglucaemic rats the alcoholic extractive 
of Arani showed comparable inhibitory 
effect to that of tolbutamide at the peak time 
of hyperglycaemia i.e. at the end of second 
hour (Table – 1).  There was not observed 
much difference in the mean percent rise per 
hour of talbutamide treated group and the 
group treated with alcoholic extractive 
(Table – 1).  On statistical analysis too, both 
the Arani decoction and tolbutamide 
exhibited equally highly significant 
(p<0.001) inhibitory effect (Table –  5).  
Therefore Arani appears well comparable to 
tolbutamide in its hypoglycaemic effect both 
in normal rats and in adrenaline induced 
hyperglycaemic rats. 
 
CLINICAL STUDY 
 
MATERIAL AND METHODS: 
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The clinical study was conducted on 23 
patients with proved diabetes mellitus in S. 
S. Hospital, B. H. U.  These patients were 
divided into four groups.  The first group 
consisting of 13 patients was treated with 
Arani decoction (1:4) in the doses of 15 to 
30 gm. of crude drug per day in divided 
doses.  Tolbutamide (500 mg/day) was 
given to the 3 diabetics of second group.   
The third group (3 patients) was treated with 
30 units of insulin daily whereas fourth 
group of 4 cases was kept was control (diet 
group) without any treatment.  The mean 
duration of treatment was 5.2 weeks in 
Arani group, 2 weeks in tolbutamide group 
2.3 weeks in insulin group.  All the patients 
were kept on same hospital diet consisting 
of 2425 calory. 
 
RESULTS AND OBSERVATIONS: 
 
The mean duration of illness was 6 years in 
this  series.  Polydypsia and polyuria were 
present in all the patients.  Weakness, 
constipation and hyperplasia were the next 
complaints.  A marked symptomatic 
improvement was observed in Arani treated 
diabetic patients.  Urine became free of 
sugar in 46% cases.  A fall in percentage of 
urine sugar was also produced in the rest of 
the cases.  Likewise, a marked reduction in 
blood sugar values of these patients was also 
observed in this study.  Mean values of 
blood sugar lowered down to 149 mg% from 
202 mg%, and that of urine sugar to 0.8 
mg% from 2.2 mg%.  The reduction in mean 
values of blood sugar was to 137 mg% from 
176 mg% in Tolbutamide group and to 191 
mg% from 276 mg% in insulin group.  The 
mean values of urine sugar came down to 
1.5 gm% from 2.7 gm% in Tolbutamide 
group and to 1.3 gm% from 3.5 gm% in 
insulin group.  However, in the control 
group the blood sugar mean values raised to 
196 mg% from 185 mg% and urine sugar 
increased to 2.5 gm% from 2.1 gm%.   
Moreover, glucose tolerance was also 
increased in Arani treated diabetic patients. 
 
DISCUSSION 
 
The observations of this clinical study 
exhibited a fall in blood sugar and urine 
sugar along with symptomatic improvement.  
The mean% weekly fall or rise was 
calculated in each group.  The values are 
shown in fig. 3.  The mean% weekly fall in 
Arani group was 7.1 in blood sugar and 18.2 
in urine sugar.  These values in Tolbutamide 
group well 11.0 and 22.2 in Tolbutamide 
group which are slightly more than Arani 
group.  However, the effect was less than 
insulin in both these groups but the fall was 
gradual.  In control group a rise in blood 
sugar and urine sugar was observed.   
Clinically too, the condition of these patients 
deteriorated.  The results are shown in fig.4.  
On the total assessment based on 
symptomatic improvement and lowering the 
blood sugar and urine sugar values the 46% 
of diabetic patients responded well to Arani 
treatment (Table –  6).  Neither did any 
patient complain of any side effect nor any 
change in routine blood values was observed 
during the course of Arani treatment. 
 
Case Report 
 
For a brief introduction, a case report is 
being described here R S U, 70 years old 
male, resident of Bihar was admitted with 
the complaints of polyuria, polydypsia, 
constipation, loss of vision, tingling and 
numbness in extremities for the duration of 
10 years and complicated with pulmonary 
tuberculosis.  Fasting blood sugar was 316 
mg% and urine contained 4.0 gm% sugar, 
30 gm% of crude drug.  Arani was given to 
him daily in decoction from in four divided 
doses.  Anti – tubercular treatment was, also 
given simultaneously.  Three weeks of Arani 
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sugar to 188 mg% and urine sugar 1.5 gm% 
(Fig. 5).  Then the dose was reduced to 22.5 
gm. crude drug daily.  During the follow up 
period, his blood sugar remained between 
130 to 140 mg under the Arani treatment.     
Sugar became absent from the urine 
Polyuria and polydyspia were improved.   
This diabetic patient responded well to 
Arani treatment without any adverse effect. 
 
Conclusion: 
 
The problem of diabetes mellitus is as old as 
humanity.  New discoveries pave the way 
for the newer adventures in the field of 
research.  Insulin turned the course of the 
history of diabetes.  The oral hypoglycaemic 
drugs helped the patient to forego the needle 
and syringe.  While insulin is only 
replacement therapy, the action of new oral 
hypoclycaemic compounds are still to be 
understood beyond doubts.  Therefore a 
search to find out better oral antidiabetic 
drug is continued.  In the present series the 
prescription of Susrutavaijayanti 
(Clerodendron phlomides) for the treatment 
of Iksumeha has been put on trial in 
experimental and clinical study.  Arani 
exhibited significant inhibitory effect on 
adrenaline induced hyperglycaemia.  In a 
comparative study, Arani  produced well 
comparable fall in blood sugar values of 
albino rats to that of a known oral 
hypoglycaemic drug tolbutamide both on 
immediate effect as well on long term use.  
Arani also brought down the blood sugar 
levels effectively in alloxan diabetic rats.  
Moreover, in clinical study Arani – 
decoction exhibited good response in 
patients with diabetes mellitus.  The fall in 
blood sugar was gradual.  It produced no 
side effects.  Comparatively / Arani showed 
somewhat similar response as that of 
tolbutamide.  Therefore, the drug Arani 
(Clerodendron phlomides) appears to be a 
good oral hypoglycaemic drug.  Vaidya et al 
(1962) have reported the efficacy of Bilva   
(Aegle marmalos) in diabetes mellitus.   
Consequently it is requested to evaluate the 
antidiabetic  potentially of the remaining 
three constituents of Brahat-pancha Moola 
viz.  Syonaka (Oroxylum indicum), patala 
(Stereospermum suaveolens) and Gambhari 
(Gmelina arborea).  Thereby the Ayurveda 
can serve the suffering humanity.   
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